GlassScriptPhysician profile
Mark Hofbauer
NPI 1841280682
$1,099,517.39
in general payments reported to CMS, 2019-2025
25 companies · $82K in 2025
The $82K reported for 2025 was more than what 99% of Podiatrist providers received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $107K · 2020: $37K · 2021: $42K · 2022: $589K · 2023: $145K · 2024: $98K · 2025: $82K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $174K · Acquisitions: $67K · Royalty Or License: $56K · Travel and Lodging: $21K · Food and Beverage: $4,480 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $2,000 · Long Term Medical Supply Or Device Loan: $154.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $173,650.46 |
| Acquisitions | $67,037.77 |
| Royalty Or License | $56,068.75 |
| Travel and Lodging | $20,757.79 |
| Food and Beverage | $4,479.89 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $2,000.00 |
| Long Term Medical Supply Or Device Loan | $153.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Linvatec Corporation | $597,424.43 | 2022-2025 | Avenger Radial Head, +4 Stems, Colink Afx, Colink Plating System |
| Stryker Corporation | $248,562.32 | 2019-2025 | Ortholoc 2 Lapifuse, Prostep, Ortholoc 3di Crosscheck |
| Trimed, INC. | $66,783.73 | 2024-2025 | |
| Wright Medical Technology, INC. | $65,884.85 | 2019-2020 | |
| In2bones USA, LLC | $44,237.11 | 2019-2022 | |
| Medshape, INC. | $44,111.45 | 2023-2025 | Dynanail Helix, Washer, 15 Mm, Dynanail, Dynanail Mini |
| Trilliant Surgical LLC. | $16,353.73 | 2022-2024 | Arsenal Ankle 10 Hole 1/3 Tubular Plate |
| Celularity INC. | $7,406.15 | 2019-2020 | |
| Synthes Gmbh | $5,686.11 | 2023-2025 | |
| Nvision Biomedical Technologies, INC. | $1,162.00 | 2021 | |
| Horizon Therapeutics Plc | $323.38 | 2019-2020 | |
| Peter Brasseler Holdings, LLC | $267.02 | 2025 | |
| Henry Schein, INC. | $261.40 | 2024-2025 | |
| Medartis INC. | $156.84 | 2020 | |
| Integra Lifesciences Corporation | $153.91 | 2025 | Micromatrix |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $145.35 | 2025 | Stravix Pl, Grafix Pl, Oasis |
| Zimmer Biomet Holdings, INC. | $142.67 | 2023 | Accufill |
| Flower Orthopedics Coporation | $100.00 | 2024 | |
| Bioventus LLC | $95.53 | 2019-2021 | |
| Encore Medical, LP | $76.72 | 2021 | |
| Abbott Laboratories | $55.90 | 2022-2025 | Proclaim |
| Orthofix Medical, INC. | $46.52 | 2025 | Physio-Stim |
| Exactech, INC. | $40.57 | 2023 | |
| Paragon 28, INC. | $20.11 | 2021 | |
| Pacira Therapeutics, INC. | $19.59 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$18,000.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Hofbauer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.